SABRINA M FOSKEY
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BROOKLYN, NY NPI 1497748446
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NY Novo Nordisk AS All categories
General Payments — all program years on this page
$6,280.50
- Category: General Payments
- Program years: PY2021–2024
- Record count: 160
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,286.15 across 48 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,286.15 | 48 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $399.90 | 13 |
| Amgen Inc. | $367.81 | 5 |
| Acerta Pharma LLC | $235.12 | 5 |
| ABBVIE INC. | $227.27 | 2 |
| PFIZER INC. | $140.70 | 3 |
| Gilead Sciences, Inc. | $125.00 | 1 |
| Teva Pharmaceuticals USA, Inc. | $125.00 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.97 | 1 |
| Otsuka America Pharmaceutical, Inc. | $124.69 | 1 |
| Lilly USA, LLC | $119.65 | 5 |
| Merck Sharp & Dohme Corporation | $58.74 | 2 |
| PROGENICS PHARMACEUTICALS, INC. | $50.00 | 1 |
| Exact Sciences Corporation | $43.42 | 2 |
| Phathom Pharmaceuticals, Inc. | $29.24 | 1 |
| Ardelyx, Inc. | $27.86 | 1 |
| Regeneron Healthcare Solutions, Inc. | $26.81 | 1 |
| Astellas Pharma US Inc | $24.73 | 1 |
| Phadia US Inc. | $21.86 | 1 |
| Esperion Therapeutics, Inc. | $13.38 | 1 |
By program year
Records — PY2024 (48)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.